For the love of the job
Elisabeth de Vries enjoys investigating whether we can push the potential of imaging techniques to the point where a patient’s response to a drug can routinely be measured in an outpatient clinic. Download full article
August 2011
Unshackling progress in the care of childhood cancers
A meeting held in the run up to International Childhood Cancer Day reviewed how well we are doing to help young cancer patients. Download full article
Think yourself better
In oncology, the contribution of the human touch which alternative medical treatments offer, and the placebo effect they induce, can be easy to overlook. Download full article
Rituximab for follicular lymphoma: maintaining an open mind
New data from the Primary Rituximab And Maintenance study provide the strongest support for the use of rituximab maintenance in patients with follicular lymphoma. However, further considerations of cost, inconvenience, toxic effects, efficacy of retreatment [more]
ASTER–another flow in the diagnostic field of lung cancer?
Mediastinal staging of patients with lung cancer is used to avoid futile thoracotomies. Endoscopic, oesophageal and bronchial ultrasound procedures are methods to identify involved lymph nodes. The ASTER study indicates that the sensitivity of these [more]
Newsround
Selected reports by Janet Fricker Download full article
Patients need information. Is that clear?
The urgent quest for novel cancer treatments engages much of our attention, but could we be overlooking other opportunities for increasing patients’ survival and quality of life? Download full article
Peter Naredi: a can do’ leader for Europe’s cancer surgeons
There are so many ways cancer surgeons can help improve outcomes, and Peter Naredi embraces them all. As ESSO president, he now hopes to enthuse Europe’s cancer surgeons to follow his lead. Download full article
Decision making in the treatment of gliomas
This overview looks at the role of age, tumour size, performance status and various predictive and prognostic biomarkers in guiding treatment in newly diagnosed and recurrent disease. Download full article
Beyond Survival–what should new cancer drugs have to prove and how?
As our understanding of cancer increases are randomised controlled trials still the way to get the best drugs into use most quickly? Download full article